181 related articles for article (PubMed ID: 33107291)
1. [Investigation of Ganciclovir Resistance in Cytomegalovirus Strains Obtained from Immunocompromised Patients].
Coşkun A; Gökahmetoğlu S; Özmen P; Çevik Ş; Karakükçü M; Kaynar L; Midilli K; Kuşkucu MA
Mikrobiyol Bul; 2020 Oct; 54(4):619-628. PubMed ID: 33107291
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of Ganciclovir Resistance in Cytomegalovirus Isolates by Phenotypic and Genotypic Methods].
Sarınoğlu RC; Çolak D; Küpesiz OA; Kuşkucu MA; Yalçın K; Sağlık İ; Mutlu D; Midilli K; Peker BO; Özhak B; Özkul A; Foldes K
Mikrobiyol Bul; 2023 Jul; 57(3):401-418. PubMed ID: 37462304
[TBL] [Abstract][Full Text] [Related]
3. [Mutations in the
Demin MV; Tikhomirov DS; Biderman BV; Drokov MY; Sudarikov AB; Tupoleva TA; Filatov FP
Vopr Virusol; 2022 Mar; 67(1):37-47. PubMed ID: 35293187
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C
J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of ganciclovir resistance in CMV UL54 and UL97 gene regions in immunocompromised patients receiving gancyclovir treatment].
Delice S; Gökahmetoğlu S; Kaynar L; Karakükcü M
Mikrobiyol Bul; 2015 Jul; 49(3):393-402. PubMed ID: 26313280
[TBL] [Abstract][Full Text] [Related]
6. [Presence of mutations associated with ganciclovir resistance in cytomegalovirus UL97 gene].
Oyarzún MA; Bustos P; González M; Domínguez MI; Aguayo F; Nervi B; Ferres M
Rev Med Chil; 2010 Apr; 138(4):421-7. PubMed ID: 20668789
[TBL] [Abstract][Full Text] [Related]
7. Recurrent and persistent cytomegalovirus infection in a kidney recipient caused by the L595S mutation in UL97 phosphotransferase gene.
Peixoto M; Mascarenhas L; Cunha A; Dutra M; Miranda E; Silva I; Costa S; Galvão B; Cunha A
Antivir Ther; 2012; 17(3):585-8. PubMed ID: 22293247
[TBL] [Abstract][Full Text] [Related]
8. Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection.
Rose J; Emery VC; Kumar D; Asberg A; Hartmann A; Jardine AG; Bignamini AA; Humar A; Neumann AU
PLoS Pathog; 2017 Apr; 13(4):e1006299. PubMed ID: 28406982
[TBL] [Abstract][Full Text] [Related]
9. The influence of mixed HCMV UL97 wildtype and mutant strains on ganciclovir susceptibility in a cell associated plaque reduction assay.
Eckle T; Jahn G; Hamprecht K
J Clin Virol; 2004 May; 30(1):50-6. PubMed ID: 15072754
[TBL] [Abstract][Full Text] [Related]
10. Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients.
Garrigue I; Moulinas R; Recordon-Pinson P; Delacour ML; Essig M; Kaminski H; Rerolle JP; Merville P; Fleury H; Alain S
J Clin Virol; 2016 Jul; 80():74-81. PubMed ID: 27214758
[TBL] [Abstract][Full Text] [Related]
11. Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child.
Iwasenko JM; Scott GM; Ziegler JB; Rawlinson WD
J Clin Virol; 2007 Oct; 40(2):152-5. PubMed ID: 17698411
[TBL] [Abstract][Full Text] [Related]
12. Viral monitoring and successful treatment of a ganciclovir-resistant cytomegalovirus infection in a heart transplant recipient.
García-Martínez J; Folgueira L; Delgado R; Hernando S; Prieto C; Aguado JM; Otero JR
Transpl Infect Dis; 2008 Apr; 10(2):123-8. PubMed ID: 17605746
[TBL] [Abstract][Full Text] [Related]
13. Persistent Primary Cytomegalovirus Infection After Deceased Donor Kidney Transplant: Ganciclovir Susceptibility of Human Cytomegalovirus With UL97 D605E Mutation: A Case Report.
Nawashiro Y; Shiraki K; Yamamoto S; Takizawa K; Sasada Y; Suehiro M; Miura K; Hattori M; Daikoku T; Hisano M
Transplant Proc; 2018 Dec; 50(10):3932-3936. PubMed ID: 30577289
[TBL] [Abstract][Full Text] [Related]
14. Molecular Epidemiology of Cytomegalovirus UL97 and UL54 variants in Taiwan.
Yang SL; Lin TW; Lin HC; Wang HY; Chang PY; Wang PN; Yang S; Lu JJ
J Microbiol Immunol Infect; 2021 Oct; 54(5):971-978. PubMed ID: 33632621
[TBL] [Abstract][Full Text] [Related]
15. Emergence and prevalence of cytomegalovirus UL97 mutations associated with ganciclovir resistance in AIDS patients.
Gilbert C; Handfield J; Toma E; Lalonde R; Bergeron MG; Boivin G
AIDS; 1998 Jan; 12(2):125-9. PubMed ID: 9468360
[TBL] [Abstract][Full Text] [Related]
16. Rapid detection and quantitation of ganciclovir resistance in cytomegalovirus quasispecies.
Ruiz-Carrascoso G; Romero-Gómez MP; Plaza D; Mingorance J
J Med Virol; 2013 Jul; 85(7):1250-7. PubMed ID: 23592041
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.
Scott GM; Isaacs MA; Zeng F; Kesson AM; Rawlinson WD
J Med Virol; 2004 Sep; 74(1):85-93. PubMed ID: 15258973
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus drug resistance mutations in transplant recipients with suspected resistance.
Recio V; González I; Tarragó D
Virol J; 2023 Jul; 20(1):153. PubMed ID: 37464399
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus UL97 ganciclovir resistance mutations in kidney transplant recipients.
Tasoujlu M; Khalafkhany D; Makhdoomi K; Motazakker M
Bratisl Lek Listy; 2022; 123(7):518-522. PubMed ID: 35907059
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir.
Chou S; Waldemer RH; Senters AE; Michels KS; Kemble GW; Miner RC; Drew WL
J Infect Dis; 2002 Jan; 185(2):162-9. PubMed ID: 11807689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
